ECO Animal Health Group plc

LSE EAH.L

ECO Animal Health Group plc Receivables for the year ending March 31, 2024: USD 37.64 M

ECO Animal Health Group plc Receivables is USD 37.64 M for the year ending March 31, 2024, a 23.05% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

ECO Animal Health Group plc Receivables for the year ending March 31, 2023 was USD 30.59 M, a -0.41% change year over year.
ECO Animal Health Group plc Receivables for the year ending March 31, 2022 was USD 30.72 M, a -25.28% change year over year.
ECO Animal Health Group plc Receivables for the year ending March 31, 2021 was USD 41.11 M, a 27.55% change year over year.
ECO Animal Health Group plc Receivables for the year ending March 31, 2020 was USD 32.23 M, a 9.78% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

LSE: EAH.L

ECO Animal Health Group plc

CEO	Mr. David Charles Hallas
IPO Date	Sept. 26, 1995
Location	United Kingdom
Headquarters	78 Coombe Road
Employees	227
Sector	Health Care
Industries Pharmaceuticals Biotechnology Pet Food

Description

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is headquartered in New Malden, the United Kingdom.

Key trends

Past 5 years